Form 4 for CHRN ChronoScale Holdings Corp
Accepted 2023-06-15 00:00:00 ET · period of report 2021-01-28 · accession 0001549084-23-000045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-06-15 | 2021-01-28+ | CHRN | Jones Jason C | COO | A - Grant | $0.00 | +15.3K | 15.3K | New | $0 |
| M | 2023-06-15 | 2023-06-12 | CHRN | Jones Jason C | COO | A - Grant | $0.00 | +190.5K | 158.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-17 | A | A | 3,346 | $0.00 | 4,491 | I | — | — | |
| 2 | Common | Common Stock | 2021-01-28 | A | A | 1,145 | $0.00 | 1,145 | I By 401K | — | — | |
| 3 | Common | Common Stock | 2023-06-12 | A | A | 170,454 | $0.00 | 329,008 | D By 401K | — | — | (F4) The RSU grant was approved by the Board of Directors in a meeting held on December 8, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of January 3, 2024, 2025 and 2026, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date. (F1) Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. (F5) Includes 251,141 unvested RSUs. |
| 4 | Common | Common Stock | 2023-06-12 | A | A | 20,000 | $0.00 | 158,554 | D By 401K | — | — | (F1) Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. (F2) The RSU grant was approved by the Board of Directors in a meeting held on December 8, 2022, on the condition that the Issuer's stockholders approved an increase in shares available for issuance under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which occurred at the Issuer's Annual Meeting on June 8, 2023, and the Issuer filed a registration statement on Form S-8 with the Securities and Exchange Commission, which occurred on June 12, 2023. 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on each of December 8, 2023, 2024 and 2025, in each case subject to the Reporting Person's continuous service with the Issuer as of each vesting date. (F3) Includes 80,867 unvested RSUs. |
| 5 | Common | Common Stock | 2023-06-12 | A | A | 10,800 | $0.00 | 15,291 | I | — | — |